Moderna stock drops 12% after 177% surge: Here’s what Wall Street says about MRNA

How 1 sources are covering this

• Hindustan TimesLean L·1h ago

  Moderna stock drops 12% after 177% surge: Here’s what Wall Street says about MRNA

  Moderna stock falls 12% after a 177% surge as investors weigh the intismeran cancer vaccine win, future demand, pricing and other cancer trials.

  Read at Hindustan Times →